Liquidia Stock (NASDAQ: LQDA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 6.000 / 869.822K |
Day Range | - - - |
52 Wk Range | 5.710 - 16.990 |
Market Cap | $940.464M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 31 |
Short Interest | 15.24% |
Days to Cover | 7.51 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Liquidia (NASDAQ: LQDA) through any online brokerage.
Other companies in Liquidia’s space includes: GH Research (NASDAQ:GHRS), Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE) and Tarsus Pharmaceuticals (NASDAQ:TARS).
The latest price target for Liquidia (NASDAQ: LQDA) was reported by Needham on Wednesday, April 10, 2024. The analyst firm set a price target for 28.00 expecting LQDA to rise to within 12 months (a possible 126.35% upside). 20 analyst firms have reported ratings in the last year.
The stock price for Liquidia (NASDAQ: LQDA) is $12.37 last updated April 25, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Liquidia.
Liquidia’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Liquidia.
Liquidia is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.